Hjem
Amra Grudic-Fetas bilde

Amra Grudic-Feta

Seniorrådgiver, Forskningsrådgiver
  • E-postAmra.Grudic@uib.no
  • Telefon+47 55 97 46 71+47 996 36 904
  • Besøksadresse
    Laboratoriebygget
    8.etg. heis øst
    5021 Bergen
  • Postadresse
    Postboks 7804
    5020 BERGEN

Støtte mot ulike finansieringskilder slik som Norges forskningsråd, EU Horisont2020, Kreftforeningen, Bergen forskningsstiftelse (BFS) med flere.

Bistår de vitenskapelig ansatte i ulike prosesser rundt søknadsskriving.

Mobilisering

Karriererådgivning

 

Vitenskapelig artikkel
  • 2018. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. International Journal of Cancer. 1735-1745.
  • 2013. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. Neuro-Oncology. 269-278.
  • 2012. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling. Blood. 847-857.
  • 2010. Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein. BMC Molecular Biology. 12 sider.
  • 2009. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins. Journal of Cell Science. 1201-1210.
  • 2007. Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres. Nucleic Acids Research. 7267-7278.
  • 2006. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. Journal of Cell Science. 3284-3295.
Mastergradsoppgave
  • 2010. The Expression and Localization of Id1 and Id3 in Glioblastoma Multiforme.
  • 2005. Characterization of a functional interplay between promyelocytic leukemia protein & replication protein A.
Doktorgradsavhandling
  • 2012. Promyelocytic leukemia bodies – functions and dynamics.
Sammendrag/abstract
  • 2010. APPLICATION OF A NOVEL P53 REPORTER ASSAY IN HUMAN GLIOBLASTOMA CELLS. Neuro-Oncology. 96-96.

Se fullstendig oversikt over publikasjoner i CRIStin.